Mr. Leo is a seasoned executive with over 30 years of leadership experience in the biomedical industry. He has held key position at esteemed organizations such as Cerevast Medical, Sonus Pharmaceuticals, and Brigham and Women’s Hospital. Renowned for his expertise in regulatory affairs and quality management, Mr. Leo has been pivotal in driving operational excellence and aligning strategic goals with product innovation. Over the course of his career, he has successfully guided pharmaceutical, medical device, and biologic products from the startup phase through the commercial launch. Mr. Leo holds a Bachelor of Science degree in Chemistry from the University of Washington.
Dr. Curra is a recognized bioengineering executive with over 20 years of academic and private sector R&D experience in the fields of ultrasound imaging, high intensity focused ultrasound (HIFU), nonlinear acoustics, and tissue bioeffects. He has developed state-of-the-art 3D models for nonlinear propagation and HIFU therapy, innovative imaging transducers, and novel monitoring and feedback imaging protocols.
Dr. Curra primary R&D emphasis has been on the development of portable, point-of-care image-guided therapy systems for targeted clinical applications. He has made significant contributions to technology development in the areas of ultrasound-based cosmetic treatments and noninvasive and laparoscopic ultrasound surgery. Dr. Curra holds a Bachelor of Science in Bioengineering from Syracuse University and a Ph.D. in Bioengineering from the University of Washington. He is the inventor of several issued patents in medical ultrasound.
Longevity Biomedical, Inc
19125 North Creek Parkway S. Suite 120, PMB 693
Bothell, WA 98011
+1 (425) 748-7529
info@longevitybiomedical.com
© 2022-2025 Longevity Biomedical Inc